Trans-Chalcone Attenuate Arsenic-Induced Toxicity in 3t3 Embryonic Fibroblast Cells; An In Vitro And In Silico Study
Loading...

Date
2024
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Open Access Color
Green Open Access
No
OpenAIRE Downloads
OpenAIRE Views
Publicly Funded
No
Abstract
This study investigated the curative role of trans-chalcone, a flanovide, against arsenic toxicity using in vitro and computer-based analyses. MTT and LDH methods were used to assess the cytotoxicity and viability of cells, spectrophotometric methods to evaluate SOD, GSH-px, MDA and PC biomarkers, and ELISA method to evaluate TNF-a IL-1(3 levels. Bax, Bcl-2 levels and Caspase-3 activity were measured by qRT-PCR technique, while TUNEL staining was performed to detect DNA breaks and DAPI staining was performed to visualize nuclear changes. In addition, computer-based analyses of trans-chalcone and Dimercaprol molecules were analyzed using SwissADME, ADMETlab, DFT web tools. Trans-chalcone treatment rescued 3T3 embryonic fibroblast cells, reduced oxidative stress. Again, trans-chalcone treatment showed positive effects on TNF-alpha, IL-1(3 levels and apoptotic markers. In conclusion, trans-chalcone showed antioxidant, anti-inflammatory, and anti-apoptotic effects against cellular toxicity caused by arsenic, as well as DFT, ADMET, drug similarity, molecular docking profiles predicted trans-chalcone to be a promising ligand. This research, based on in vitro and in silico analyses, may be useful in the development of promising drug(s) to reduce toxicity.
Description
UNSAL, VELID/0000-0003-1415-0563
Keywords
Trans-Chalcone, Arsenic, Dft, Moleculer Docking, In Silico
Fields of Science
Citation
WoS Q
Q2
Scopus Q
Q1

OpenCitations Citation Count
N/A
Source
Journal of Molecular Structure
Volume
1318
Issue
Start Page
End Page
PlumX Metrics
Citations
Scopus : 8
Captures
Mendeley Readers : 6
SCOPUS™ Citations
8
checked on Mar 18, 2026
Web of Science™ Citations
7
checked on Mar 18, 2026
Page Views
1
checked on Mar 18, 2026
Google Scholar™


